1. Prognostic Impact of Age and Hemoglobin in Acute ST-Segment Elevation Myocardial Infarction Treated With Reperfusion Therapy
- Author
-
Iago Sousa-Casasnovas, Rocío Angulo-Llanos, Manuel Martínez-Sellés, María Jesús Valero-Masa, Miriam Juárez, Felipe Díez-Delhoyo, Francisco Fernández-Avilés, Jesús Velásquez-Rodríguez, Lourdes Vicent, and Carolina Devesa
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Enfermedad cardiovascular ,Myocardial Reperfusion ,030204 cardiovascular system & hematology ,Risk Assessment ,Hemoglobins ,03 medical and health sciences ,0302 clinical medicine ,Reperfusion therapy ,Risk Factors ,Internal medicine ,medicine ,Humans ,Thrombolytic Therapy ,Hospital Mortality ,030212 general & internal medicine ,Myocardial infarction ,Aged ,Retrospective Studies ,Killip class ,Ejection fraction ,business.industry ,Hazard ratio ,Age Factors ,Percutaneous coronary intervention ,Odds ratio ,Middle Aged ,Prognosis ,medicine.disease ,Survival Rate ,Spain ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,Infarto de miocardio ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Follow-Up Studies ,Kidney disease - Abstract
Advanced age and low hemoglobin levels have been associated with a poor prognosis in ST-segment elevation myocardial infarction (STEMI). We studied 1,111 patients with STEMI who received reperfusion treatment (1,032 [92.9%] primary angioplasty and 79 [7.1%] fibrinolysis without rescue percutaneous coronary intervention). Mean age was 64.1 ± 14.0 years, and 23.2% were women. Patients in the last age quartile (>76 years) were more frequently women, presented more risk factors (except smoking), received thrombolysis less frequently, had less complete revascularization, and presented more complications and higher mortality. Hemoglobin level at admission was associated with age and ranged from 14.8 ± 1.5 g/dl in the first quartile to 13.2 ± 1.8 g/dl in the last, p
- Published
- 2017
- Full Text
- View/download PDF